Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Michigan

CNS trials open to children and teens in Michigan

12 CNS studies open to children and teens are recruiting participants at sites in 6 cities across Michigan as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Michigan city with a recruiting study

By research area: Migraine (4), Epilepsy (3), ADHD (2), Depression (2), Schizophrenia (1).

Ann Arbor (6), Bloomfield Hills (3), Grand Rapids (3), Detroit (1), Marquette (1), Royal Oak (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in Michigan

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Bloomfield Hills
    Registry record
    NCT04781140 · updated
  2. NeuroTrainer Cognitive Training For Academic Focus

    • No phase
    • Ages 11 to 17
    • All sexes
    Sponsor
    NeuroTrainer
    Recruiting in
    Marquette
    Registry record
    NCT06512974 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Michigan on ClinicalTrials.gov.

Depression: recently updated in Michigan

  1. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    • No phase
    • Ages 12 to 22
    • All sexes
    Sponsor
    Michigan State University
    Recruiting in
    Grand Rapids
    Registry record
    NCT06232304 · updated
  2. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Bloomfield Hills
    Registry record
    NCT06372964 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Michigan on ClinicalTrials.gov.

Epilepsy: recently updated in Michigan

  1. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Recruiting in
    Ann Arbor
    Registry record
    NCT07531745 · updated
  2. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Recruiting in
    Ann Arbor
    Registry record
    NCT05419492 · updated
  3. Functional Brain Mapping for Patients with Epilepsy

    • No phase
    • From 6 months, up to 21 years
    • All sexes
    Sponsor
    Wayne State University
    Recruiting in
    Detroit
    Registry record
    NCT05755919 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Michigan on ClinicalTrials.gov.

Migraine: recently updated in Michigan

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Ann Arbor · Grand Rapids
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Ann Arbor · Grand Rapids · Royal Oak
    Registry record
    NCT04743141 · updated
  3. A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Ann Arbor
    Registry record
    NCT06810505 · updated
  4. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Ann Arbor
    Registry record
    NCT05711394 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Michigan on ClinicalTrials.gov.

Schizophrenia: recently updated in Michigan

  1. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Bloomfield Hills
    Registry record
    NCT06229210 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Michigan on ClinicalTrials.gov.

Ask about studies in Michigan

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call